secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANI PHARMACEUTICALS INC (ANIP)
CIK:        0001023024
Form:       8-K
Filed at:   2024-05-14T23:59:59+00:00
Accession:  0001023024-24-000059
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ANI Pharmaceuticals CEO presents at investor conference; no financial results disclosed in filing
--------------------------------------------------------------------------------

- President & CEO Nikhil Lalwani participated in Capital One Securities Biotech/Biopharma Disruptors Event on May 14, 2024.
- Investor presentation attached as Exhibit 99.1 was referenced but not included in the provided text.
- No new financial or operational data, guidance changes, or material events can be extracted from the filing alone.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023024/000102302424000059/0001023024-24-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023024/000102302424000059/ani-20240514.htm
  HTML page:      https://secwatch.observer/filing/0001023024-24-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer